lactic acid has been researched along with Hepatitis B, Chronic in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "None of the patients developed lactic acidosis during follow-up [median: 58 (6-155) months]." | 3.85 | Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis. ( Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G, 2017) |
| " L-FMAU also has respectable bioavailability in rats." | 2.40 | Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. ( Boudinot, FD; Cheng, YC; Choi, Y; Chu, CK; Cote, PJ; Gerin, JL; Hong, JH; Korba, BE; Peek, SF; Tennant, BC, 1998) |
| "Twenty-nine patients with chronic hepatitis B (CHB), 28 with compensated LC, 33 with decompensated LC, 24 with spontaneous bacterial peritonitis (SBP), 26 with acute-on-chronic liver failure (ACLF), and 24 with decompensated LC complicated by hepatocellular carcinoma (HCC) were recruited." | 1.51 | Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease. ( Biviano, I; Gong, Z; Hu, J; Liu, H; Wang, A; Wang, Z, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, T | 1 |
| Hu, F | 1 |
| Yue, H | 1 |
| Yang, T | 1 |
| Ma, G | 1 |
| Chen, W | 1 |
| You, J | 1 |
| Chen, J | 1 |
| Zhu, Y | 1 |
| Triantos, C | 1 |
| Kalafateli, M | 1 |
| Aggeletopoulou, I | 1 |
| Mandellou, M | 1 |
| Assimakopoulos, S | 1 |
| Tselekouni, P | 1 |
| Taprantzi, D | 1 |
| Tsiaoussis, G | 1 |
| Vourli, G | 1 |
| Anastassiou, ED | 1 |
| Gogos, C | 1 |
| Labropoulou-Karatza, C | 1 |
| Thomopoulos, K | 1 |
| Ayoub, MM | 1 |
| Elantouny, NG | 1 |
| El-Nahas, HM | 1 |
| Ghazy, FES | 1 |
| Wang, Z | 1 |
| Wang, A | 1 |
| Gong, Z | 1 |
| Biviano, I | 1 |
| Liu, H | 1 |
| Hu, J | 1 |
| Yao, YH | 1 |
| Zhao, WF | 1 |
| Gan, JH | 1 |
| Chu, CK | 1 |
| Boudinot, FD | 1 |
| Peek, SF | 1 |
| Hong, JH | 1 |
| Choi, Y | 1 |
| Korba, BE | 1 |
| Gerin, JL | 1 |
| Cote, PJ | 1 |
| Tennant, BC | 1 |
| Cheng, YC | 1 |
1 review available for lactic acid and Hepatitis B, Chronic
| Article | Year |
|---|---|
Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Biological Availability; Cell Line; Deoxycytidine | 1998 |
6 other studies available for lactic acid and Hepatitis B, Chronic
| Article | Year |
|---|---|
The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B.
Topics: Adjuvants, Immunologic; Animals; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Ch | 2020 |
Combining the serum lactic acid level and the lactate clearance rate into the CLIF-SOFA score for evaluating the short-term prognosis of HBV-related ACLF patients.
Topics: Acute-On-Chronic Liver Failure; Adult; Female; Hepatitis B, Chronic; Humans; Lactic Acid; Male; Midd | 2020 |
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therap | 2017 |
Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B.
Topics: Adenine; Animals; Antiviral Agents; Drug Delivery Systems; Drug Liberation; Hepatitis B, Chronic; La | 2018 |
Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Analysis of Variance; Biomarkers; Carcinoma, Hepatocell | 2019 |
[Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure: a retrospective analysis of 97 cases].
Topics: Acute-On-Chronic Liver Failure; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lactic Acid; Progno | 2019 |